What's in Southern Europe New Drug Organization's pipeline?

Southern Europe New Drug Organization has 3 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Southern Europe New Drug Organization's portfolio?

Top competitors by shared drug class: Aclaris Therapeutics, Inc., Astellas Pharma Global Development, Inc., AstraZeneca.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/southern-europe-new-drug-organization.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Southern Europe New Drug Organization — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Southern Europe New Drug Organization pipeline: 0 marketed, 0 filed, 0 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aclaris Therapeutics, Inc. · 1 shared drug class
Astellas Pharma Global Development, Inc. · 1 shared drug class
AstraZeneca · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Southern Europe New Drug Organization:

Cite this brief

Drug Landscape (2026). Southern Europe New Drug Organization — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/southern-europe-new-drug-organization. Accessed 2026-05-17.